Impact of protracted venous infusion fluorouracil with or without interferon alfa-2b on tumor response, survival, and quality of life in advanced colorectal cancer

Journal of Clinical Oncology

Volumn 13, Issue 9, 1995, Pages 2317-2323

  Hill, Mark ^a   Norman, Andrew ^a   Cunningham, David ^a   Findlay, Michael ^a   Watson, Maggie ^a   Nicolson, Viola ^a   Webb, Andrew ^a   Middleton, Gary ^a   Ahmed, Fareeda ^a   Hickish, Tamas ^a   Nicolson, Marianne ^a   O'Brien, Mary ^a   Iveson, Timothy ^a   Iveson, Angela ^a   Evans, Christopher ^a  

^a ROYAL MARSDEN HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA2B INTERFERON; CODEINE PHOSPHATE; FLUOROURACIL; NONSTEROID ANTIINFLAMMATORY AGENT; PARACETAMOL; PYRIDOXINE; SUCRALFATE; WARFARIN;

ADOLESCENT; ADULT; AGED; ALOPECIA; ANEMIA; ARTICLE; BONE MARROW TOXICITY; CANCER COMBINATION CHEMOTHERAPY; CANCER PALLIATIVE THERAPY; CANCER SURVIVAL; CLINICAL TRIAL; COLORECTAL CANCER; DIARRHEA; ERYTHEMA; FEMALE; FEVER; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; LETHARGY; LEUKOPENIA; MAJOR CLINICAL STUDY; MALE; MUCOSA INFLAMMATION; NAUSEA; NEUTROPENIA; ORAL DRUG ADMINISTRATION; PHASE 3 CLINICAL TRIAL; PRIORITY JOURNAL; QUALITY OF LIFE; SUBCUTANEOUS DRUG ADMINISTRATION; TREATMENT OUTCOME;

EID: 0029131435     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.1995.13.9.2317     Document Type: Article

References (31)

1. Mayer RJ: Chemotherapy for metastatic colorectal cancer. Cancer 70:1414-1424, 1992
2. Scheithauer W, Rosen H, Kornek G-V, et al: Randomised comparison of combination chemotherapy plus supportive care with supportive care alone in patients with metastatic colorectal cancer. BMJ 306:752-755, 1993
3. The Nordic Gastrointestinal Tumour Adjuvant Therapy Group: Expectancy or primary chemotherapy in patients with advanced asymptomatic colorectal cancer: A randomized trial. J Clin Oncol 10:904-911, 1992
4. Allen-Mersh TG, Earlam S, Fordy C, et al: Quality of life and survival with continuous hepatic-artery floxuridine infusion for colorectal liver metastases. Lancet 344:1255-1260, 1994
5. Advanced Colorectal Cancer Meta-Analysis Project: Modulation of flourouracil by leucovorin in patients with advanced colorectal cancer: Evidence in terms of response rate. J Clin Oncol 10:896-903, 1992
6. Advanced Colorectal Cancer Meta-Analysis Project: Meta-analysis of randomized trials testing the biochemical modulation of flourouracil by methotrexate in metastatic colorectal cancer. J Clin Oncol 12:960-969, 1994
7. Moertel CG: Chemotherapy for colorectal cancer. N Engl J Med 330:1136-1142, 1990
8. Elias L, Sandoval JM: Interferon effects upon flourouracil metabolism by HL-60 cells. Biochem Biophys Res Commun 163:867-874, 1989
9. Houghton JA, Morton C, Adkins D, et al: Locus of the interaction among 5-flourouracil, leucovorin and interferon-α2a in colon carcinoma cells. Cancer Res 53:4243-4250, 1993
10. Chu E, Zinn S, Boarman D, et al: Interaction of gamma interferon and 5-flourouracil in H630 human colon carcinoma cell line. Cancer Res 50:5834-5840, 1990
11. Pfeffer LM, Tamm I: Interferon inhibition of thymidine incorporation into DNA through effects on thymidine transport and uptake. J Cell Physiol 121:431-436, 1984
12. Wadler S, Schwartz EL, Goldman M, et al: Flourouracil and recombinant alfa-2a-interferon: an active regimen against colorectal carcinoma. J Clin Oncol 7:1769-1775, 1989
13. Wadler S, Lembersky B, Atkins M, et al: Phase II trial of flourouracil and recombinant interferon alfa-2a in patients with advanced colorectal carcinoma: An Eastern Cooperative Oncology Group study. J Clin Oncol 9:1806-1810, 1991
14. Kemeny N, Younes A, Seiter K et al: Interferon alpha-2A and 5-flourouracil for advanced colorectal carcinoma. Assessment of activity and toxicity. Cancer 66:2470-2475, 1990
15. Pazdur R, Ajani JA, Patt YZ, et al: Phase II study of flourouracil and recombinant interferon alfa-2a in previously untreated advanced colorectal carcinoma. J Clin Oncol 8:2027-2031, 1990
16. York M, Greco FA, Figlin RA, et al: A randomised phase III trial comparing 5-FU with or without interferon alfa 2a for advanced colorectal cancer. Proc Am Soc Clin Oncol 12:200, 1993 (abstr 590)
17. Hill ME, Norman AR, Cunningham D, et al: The Royal Marsden phase III trial of weekly bolus 5-fluorouracil with or without interferon-α in advanced colorectal cancer. J Clin Oncol 13:1297-1302, 1995
18. Findlay MP, Hill AS, Cunningham D, et al: Protracted venous infusion 5-flourouracil and interferon-α in advanced and refractory colorectal cancer. Ann Oncol 5:239-243, 1994
19. Lokich JJ, Ahlgren JD, Cullo JJ, et al: A prospective randomised comparison of continuous infusion flourouracil with a conventional bolus schedule in metastatic colorectal carcinoma: A Mid Atlantic Oncology Program study. J Clin Oncol 7:425-432, 1989
20. Hansen R, Ryan L, Anderson T, et al: A phase III trial of bolus 5-FU versus protracted infusion 5-FU +/- cisplatin in metastatic colorectal cancer. An Eastern Co-operative Oncology Group study. Proc Am Soc Clin Oncol 10:154, 1991 (abstr 482)
21. Miller AB, Hoogstraaten B, Staquet M, et al: Reporting results of cancer treatment. Cancer 47:207-214, 1981
22. Kaplan EL, Meier P: Non parametric estimation from incomplete observations. J Am Stat Assoc 53:457-481, 1958
23. Peto R, Peto J: Asymtotically efficient invariant procedures. J R Stat Soc A 135:185-206, 1972
24. Rubin P, Wasserman TH: The late effects of toxicity scoring. Int J Radiat Oncol Biol Phys 14:529-538, 1988
25. Aaronson NK, Ahmedzai S, Bergman B, et al: The European Organization for Research and Treatment of Cancer QLQ-C30: A quality-of-life instrument for use in the international clinical trials in oncology. J Natl Cancer Inst 85:365-376, 1993
26. Ringdal GI, Ringdal K: Testing the EORTC Quality of Life Questionnaire on cancer patients with heterogeneous diagnoses. Qual Life Res 2:129-140, 1993
27. Dufour P, Husseini F, Dreyfuss B, et al: Randomised study of 5-fluorouracil (5-FU) vs 5-FU + alpha 2a Interferon (IFN) for metastatic colorectal carcinoma (MCRC). Ann Oncol 5:44, 1994 (abstr 220)
28. Kocha W: 5-Fluorouracil (5FU) plus interferon alfa-2a (Roferon-A) vs 5FU plus leucovorin (LV) in metastatic colorectal cancer. Results of a multicenter, multinational phase III study Proc Am Soc Clin Oncol 12:199, 1993 (abstr 562)
29. Seymour MT, Slevin M, Cunningham D, et al: A randomised trial to assess the addition of interferon-alpha 2a to 5-fluorouracil (5FU) and leucovorin (LV) in advanced colorectal cancer. Ann Oncol 5:48, 1994 (abstr 237)
30. Kreuser ED, Küchler T, Matthias-M, et al: A Multicenter randomised trial with the assessment of the quality of life in patients with metastatic colorectal carcinoma given either folinic acid or interferon alpha-2b as a modulator of 5-fluorouracil. Ann Oncol 5:45, 1994 (abstr 221)
31. Pensel R: Advanced colon cancer: A randomised trial of fluorouracil (5-FU) + folinic acid (FA) and 5-FU + FA + interferon alpha 2b. Proc Am Soc Clin Oncol 12:203, 1993 (abstr 602)